| Dr James W Egel, MD | |
|
613 23rd St Ste 130, Ashland, KY 41101-2876 | |
| (606) 329-9335 | |
| (606) 324-6383 |
| Full Name | Dr James W Egel |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 46 Years |
| Location | 613 23rd St Ste 130, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750375135 | NPI | - | NPPES |
| 0560727 | Medicaid | OH | |
| 0087997000 | Medicaid | WV | |
| 390001591 | Other | KY | RAILROAD MEDICARE |
| 64235831 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 23583 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Ashland | Ashland, KY | Dialysis facility |
| Fmc - Greenup | Greenup, KY | Dialysis facility |
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
| Premier Therapy And Health Centers Inc | 7416859574 | 171 |
News Archive
DiscoveryBioMed, Inc. (DBM), a human cell-based drug discovery company, learned recently that its Cystic Fibrosis Corrector Ligand (CFCL) Drug Discovery program will be funded by the NIH. The two-year award will focus on validation and prioritization of several lead CFCL chemical classes, drugs that correct the most common cystic fibrosis (CF) disease-causing mutation.
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
Three decades after the first cases of AIDS were recorded, more than 60 million people have been infected worldwide. Scientists agree that the epidemic is far from over and, even with major treatment advances and improvement in understanding the illness, hurdles remain in the effort to eradicate the disease.
Multiple sclerosis is not a single condition, but an ebbing and flowing of stages affecting the body ' s central nervous system.
Health Data Research (HDR) UK has announced a £3.4m innovative data initiative in the North of England that will benefit patients across the UK and help address some of the most challenging health issues facing patients and the NHS.
› Verified 1 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
DiscoveryBioMed, Inc. (DBM), a human cell-based drug discovery company, learned recently that its Cystic Fibrosis Corrector Ligand (CFCL) Drug Discovery program will be funded by the NIH. The two-year award will focus on validation and prioritization of several lead CFCL chemical classes, drugs that correct the most common cystic fibrosis (CF) disease-causing mutation.
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
Three decades after the first cases of AIDS were recorded, more than 60 million people have been infected worldwide. Scientists agree that the epidemic is far from over and, even with major treatment advances and improvement in understanding the illness, hurdles remain in the effort to eradicate the disease.
Multiple sclerosis is not a single condition, but an ebbing and flowing of stages affecting the body ' s central nervous system.
Health Data Research (HDR) UK has announced a £3.4m innovative data initiative in the North of England that will benefit patients across the UK and help address some of the most challenging health issues facing patients and the NHS.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James W Egel, MD Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-6200 | Dr James W Egel, MD 613 23rd St Ste 130, Ashland, KY 41101-2876 Ph: (606) 329-9335 |
News Archive
DiscoveryBioMed, Inc. (DBM), a human cell-based drug discovery company, learned recently that its Cystic Fibrosis Corrector Ligand (CFCL) Drug Discovery program will be funded by the NIH. The two-year award will focus on validation and prioritization of several lead CFCL chemical classes, drugs that correct the most common cystic fibrosis (CF) disease-causing mutation.
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
Three decades after the first cases of AIDS were recorded, more than 60 million people have been infected worldwide. Scientists agree that the epidemic is far from over and, even with major treatment advances and improvement in understanding the illness, hurdles remain in the effort to eradicate the disease.
Multiple sclerosis is not a single condition, but an ebbing and flowing of stages affecting the body ' s central nervous system.
Health Data Research (HDR) UK has announced a £3.4m innovative data initiative in the North of England that will benefit patients across the UK and help address some of the most challenging health issues facing patients and the NHS.
› Verified 1 days ago
Padma Venkatraman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 101 Ashland Dr, Ashland, KY 41101 Phone: 606-324-1996 Fax: 606-833-2430 | |
Amr Idris, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Paula K Larsen, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1000 Ashland Dr Ste G1, Ashland, KY 41101 Phone: 606-408-4900 Fax: 606-408-6643 | |
Michael Don Canty, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 11, Ashland, KY 41101 Phone: 606-324-3188 Fax: 606-329-2237 | |
Dr. Ryann Acquino Pangan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 Fax: 606-324-6383 | |
Dr. Francisco Fernandez-gonzalez, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 310, Ashland, KY 41101 Phone: 606-833-2161 | |
Dr. Chad Jacob Tarabolous, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 19, Ashland, KY 41101 Phone: 606-325-2221 Fax: 606-324-1326 |